The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity
Bliddal H, Leeds AR, Christensen R
During her initial consultation, Dr
Clinical trials have demonstrated that GLP-1 agonists can reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death [5, 7]
Suicidal behaviors, defined as hospitalization for suicide attempts or death by suicide, were identified using International Classification of Diseases, 10th Revision (ICD-10) codes
In the RECAP post hoc cohort [42], adults with T2D treated with combined SGLT2i + GLP-1RA (liraglutide or dulaglutide) were evaluated to determine whether treatment sequence or molecule choice influenced renal outcomes